PCSK9 and mood disorder: In summary, here we have demonstrated that long-term use of PCSK9is, proxied genetically, which target PCSK9 protein levels are unlikely to increase the risk of mood disorder traits, consistent with our previous work using PCSK9 gene expression to mimic siRNA PCSK9is.